3SBio Revenue

In the year 2024, 3SBio had annual revenue of 9.11B CNY with 16.53% growth. 3SBio had revenue of 4.72B in the half year ending December 31, 2024, with 25.12% growth.

Revenue

9.11B CNY

Revenue Growth

+16.53%

P/S Ratio

3.30

Revenue / Employee

1.63M CNY

Employees

5,577

Market Cap

31.09B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.11B	1.29B	16.53%
Dec 31, 2023	7.82B	950.20M	13.84%
Dec 31, 2022	6.87B	483.73M	7.58%
Dec 31, 2021	6.38B	794.37M	14.22%
Dec 31, 2020	5.59B	269.55M	5.07%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeiGene	29.60B
Hansoh Pharmaceutical Group Company	13.05B
WuXi Biologics	19.87B
JD Health International	61.89B
Innovent Biologics	10.03B
Akeso	2.26B
Alibaba Health Information Technology	31.39B
Sichuan Kelun-Biotech Biopharmaceutical	2.06B

Revenue Rankings